Hsbc Holdings PLC Allogene Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 52,387 shares of ALLO stock, worth $118,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,387

Previous 44,664 17.29%

Holding current value

$118,918

Previous $104,000 40.38%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.08 - $3.5 $16,063 - $27,030	7,723 Added 17.29%	52,387 $146,000
Q2 2024 Aug 12, 2024	SELL	$2.23 - $4.38 $21,077 - $41,399	-9,452 Reduced 17.47%	44,664 $104,000
Q1 2024 May 15, 2024	BUY	$2.92 - $5.63 $27,599 - $53,214	9,452 Added 21.16%	54,116 $241,000
Q4 2023 Feb 12, 2024	BUY	$2.28 - $3.5 $65,000 - $99,781	28,509 Added 176.47%	44,664 $143,000
Q3 2023 Nov 13, 2023	BUY	$3.17 - $5.96 $51,211 - $96,283	16,155 New	16,155 $51,000
Q2 2022 Aug 11, 2022	SELL	$6.78 - $12.28 $114,778 - $207,888	-16,929 Reduced 59.55%	11,500 $131,000
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $89,352 - $178,587	11,680 Added 69.74%	28,429 $261,000
Q4 2021 Feb 11, 2022	SELL	$13.13 - $24.52 $135,475 - $252,997	-10,318 Reduced 38.12%	16,749 $249,000
Q3 2021 Nov 12, 2021	SELL	$21.01 - $27.64 $323,406 - $425,462	-15,393 Reduced 36.25%	27,067 $698,000
Q2 2021 Aug 13, 2021	BUY	$23.49 - $35.8 $727,250 - $1.11 Million	30,960 Added 269.22%	42,460 $1.11 Million
Q1 2021 May 14, 2021	SELL	$25.79 - $39.02 $105,996 - $160,372	-4,110 Reduced 26.33%	11,500 $405,000
Q4 2020 Feb 12, 2021	SELL	$25.24 - $43.45 $29,177 - $50,228	-1,156 Reduced 6.89%	15,610 $393,000
Q3 2020 Nov 12, 2020	BUY	$32.38 - $44.96 $170,513 - $236,759	5,266 Added 45.79%	16,766 $634,000
Q2 2020 Aug 14, 2020	SELL	$18.39 - $54.04 $26,463 - $77,763	-1,439 Reduced 11.12%	11,500 $492,000
Q1 2020 May 15, 2020	BUY	$18.22 - $28.25 $235,748 - $365,526	12,939 New	12,939 $245,000

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Allogene Therapeutics, Inc. Transaction History